We are live on ! Find out more
MJN

Mead Johnson Nutrition Company
MJN

Delisted

MJN was delisted on the 14th of June, 2017.

505 hedge funds and large institutions have $15.4B invested in Mead Johnson Nutrition Company in 2014 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 197 increasing their positions, 170 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 35

16% more repeat investments, than reductions

Existing positions increased: 197 | Existing positions reduced: 170

5% more funds holding

Funds holding: 483505 (+22)

1% less capital invested

Capital invested by funds: $15.5B → $15.4B (-$117M)

32% less call options, than puts

Call options by funds: $91.2M | Put options by funds: $133M

42% less funds holding in top 10

Funds holding in top 10: 127 (-5)

Holders
505
Holders Change
+22
Holders Change %
+4.55%
% of All Funds
14.58%
Holding in Top 10
7
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-41.67%
% of All Funds
0.2%
New
62
Increased
197
Reduced
170
Closed
35
Calls
$91.2M
Puts
$133M
Net Calls
-$42.1M
Net Calls Change
+$217M
Name Holding Trade Value Shares
Change
Change in
Stake
QSS
376
Quantitative Systematic Strategies
Florida
$403K +$198K +2,447 +102%
Thrivent Financial for Lutherans
377
Thrivent Financial for Lutherans
Minnesota
$393K
WAM
378
Wolverine Asset Management
Illinois
$385K -$1.3M -16,000 -78%
EVM
379
Eaton Vance Management
Massachusetts
$381K +$3.24K +40 +0.9%
AI
380
Atria Investments
North Carolina
$375K +$29.4K +363 +9%
CAN
381
Cetera Advisor Networks
California
$369K +$7.54K +93 +2%
Schroder Investment Management Group
382
Schroder Investment Management Group
United Kingdom
$365K +$59.6K +735 +20%
ZIM
383
Zacks Investment Management
Illinois
$363K -$209K -2,582 -37%
TIA
384
Tiemann Investment Advisors
California
$346K -$40.5K -500 -11%
CC
385
Cannell & Co
New York
$346K +$338K +4,167 New
ECM
386
Everence Capital Management
Indiana
$334K +$325K +4,013 New
CC
387
ClearArc Capital
Ohio
$333K +$19.5K +241 +6%
AIP
388
Ameritas Investment Partners
Nebraska
$331K -$26K -321 -7%
CBU
389
CIBC Bank USA
Illinois
$324K
PAM
390
Princeton Alpha Management
New Jersey
$320K -$251K -3,094 -45%
NCA
391
NCM Capital Advisers
North Carolina
$320K -$199K -2,450 -39%
CC
392
Cipher Capital
New York
$320K +$312K +3,843 New
CI
393
Constellation Investments
Ohio
$312K
PSUF
394
People's United Financial
Connecticut
$307K +$300K +3,695 New
OA
395
OFI Advisors
Pennsylvania
$303K +$23.8K +294 +9%
MLL
396
Moody Lynn & Lieberson
Massachusetts
$300K -$1.7M -20,943 -85%
BG
397
Bahl & Gaynor
Ohio
$296K -$2.43K -30 -0.8%
MSTVIM
398
Messner & Smith Theme Value Investment Management
California
$296K
PCM
399
Prelude Capital Management
New York
$291K -$81.1K -1,000 -22%
PWM
400
Perigon Wealth Management
California
$291K +$2.03K +25 +0.7%

MJN Hedge Fund Activity: Q1 2014 in Review

505 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Mead Johnson Nutrition Company (MJN) for Q1 2014, worth a combined $15.4B — down 0.76% from $15.5B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new MJN positions and 35 closed out — a net gain of 27 holders — while 197 added to existing stakes and 170 trimmed.

The largest buyer was Manning & Napier Advisors, adding an estimated $193M. The largest seller was Lone Pine Capital, exiting entirely with an estimated $298M sold.

  • 505 institutional investors held Mead Johnson Nutrition Company (MJN) as of Q1 2014, up from 483 in Q4 2013.
  • Funds reported $15.4B of Mead Johnson Nutrition Company stock for Q1 2014, down 0.76% quarter-over-quarter.
  • 62 funds opened new Mead Johnson Nutrition Company positions in Q1 2014 and 35 closed out, a net change of +27 holders.
  • The largest Mead Johnson Nutrition Company buyer in Q1 2014 was Manning & Napier Advisors, an estimated $193M added.
  • The largest Mead Johnson Nutrition Company seller in Q1 2014 was Lone Pine Capital, an estimated $298M sold.

Based on aggregated 13F filings for Q1 2014.